HALTHCC as a novel tumor response metric in patients with hepatocellular carcinoma undergoing locoregional therapy while awaiting liver transplantation. (March 2018) - Sasaki, K.; Firl, D.J.; Kimura, S.; McVey, J.; Fontan, F.; Hashimoto, K.; Yeh, H.; Miller, C.M.; Markmann, J.F.; Aucejo, N.F.